Peak Ridge Capital

Zurex Pharmacy is a specialty pharmacy and medical technology company with a novel antimicrobial technology platform. Their company's mission is to develop and commercialize a portfolio of new antimicrobial products designed to prevent healthcare-acquired infections with a focus on surgical site wounds and catheter-related infections. It was founded in 2010 and is headquartered in Middleton, Wisconsin.

Zurex Pharmacy is a specialty pharmacy and medical technology company with a novel antimicrobial technology platform. Their company's mission is to develop and commercialize a portfolio of new antimicrobial products designed to prevent healthcare-acquired infections with a focus on surgical site wounds and catheter-related infections. It was founded in 2010 and is headquartered in Middleton, Wisconsin.

Xolve, Inc., a nanomaterials company, produces and supplies graphene that is used to improve the properties of various industrial plastics for use in automotive, aerospace, electronics, and other applications. It offers graphene-loaded polymer master batches, pristine graphene nanoplatelets, and exfoliated graphene. Xolve, Inc. was formerly known as Graphene Solutions, Inc. and changed its name to Xolve, Inc. in September 2010. The company was founded in 2008 and is based in Middleton, Wisconsin. As of March 31, 2016, Xolve, Inc. operates as a subsidiary of Reliance Industries Limited.

Zurex Pharmacy is a specialty pharmacy and medical technology company with a novel antimicrobial technology platform. Their company's mission is to develop and commercialize a portfolio of new antimicrobial products designed to prevent healthcare-acquired infections with a focus on surgical site wounds and catheter-related infections. It was founded in 2010 and is headquartered in Middleton, Wisconsin.

Zurex Pharmacy is a specialty pharmacy and medical technology company with a novel antimicrobial technology platform. Their company's mission is to develop and commercialize a portfolio of new antimicrobial products designed to prevent healthcare-acquired infections with a focus on surgical site wounds and catheter-related infections. It was founded in 2010 and is headquartered in Middleton, Wisconsin.

Rapid Diagnostek, formerly known as Intellignostics, specializes in the development of a patented biosensor technology designed for rapid detection of bacteria, viruses, spores, and disease biomarkers. The company’s IntelliProbe Immunosensor platform enables point-of-sampling results in under 60 seconds, significantly reducing the time and cost associated with traditional diagnostic methods, which often take hours to days. This innovative technology targets various markets, including human and veterinary diagnostics, environmental testing, biohazard detection, bioterrorism preparedness, agricultural commodity evaluation, and food safety. Having demonstrated effective performance in laboratory settings, Rapid Diagnostek is focused on advancing its product to a fully operational device and initial assays, with the aim of moving towards commercialization.

Rapid Diagnostek, formerly known as Intellignostics, specializes in the development of a patented biosensor technology designed for rapid detection of bacteria, viruses, spores, and disease biomarkers. The company’s IntelliProbe Immunosensor platform enables point-of-sampling results in under 60 seconds, significantly reducing the time and cost associated with traditional diagnostic methods, which often take hours to days. This innovative technology targets various markets, including human and veterinary diagnostics, environmental testing, biohazard detection, bioterrorism preparedness, agricultural commodity evaluation, and food safety. Having demonstrated effective performance in laboratory settings, Rapid Diagnostek is focused on advancing its product to a fully operational device and initial assays, with the aim of moving towards commercialization.